Cargando…
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
Colorectal cancer (CRC) is the third most common cancer in men and the second most common cancer in women, worldwide. In the early stages of the disease, biomarkers predicting early relapse would improve survival rates. In metastatic patients, the use of predictive biomarkers could potentially resul...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235799/ https://www.ncbi.nlm.nih.gov/pubmed/30479461 http://dx.doi.org/10.3748/wjg.v24.i42.4738 |